Price alert —
Sign in to get a one-time email the moment MRNA crosses your price. Free accounts included.
Sign in / create a free accountModerna, Inc. is a healthcare company listed in the US.
MRNA last traded at $61.82, down 2.1% on the day; that's in the middle part of its 52-week range ($36.65–$85.60). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 46), the trend is strong (ADX 31), and trading is light at 0.5× normal volume. On the business side, revenue is growing 260% year over year and the business keeps about -1 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
The model's verdict is “Unknown” and accounting quality screens as Adequate. Model estimates only — do your own due diligence.
- ✓ More cash than debt
- ✓ Quick ratio 2.71 (antifragile)
- ✓ Current ratio 3.29 (antifragile)
- ✓ Debt/equity 0.43 (antifragile)
- ⚠ Inventory growing faster than revenue
- ⚠ Stock comp 25% of revenue (heavy dilution)
MRNA is a $27.1 billion company.